Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000820064 | SCV000960758 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311798 | SCV001502112 | uncertain significance | not provided | 2020-07-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002290467 | SCV002579647 | uncertain significance | Tay-Sachs disease | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002442748 | SCV002732004 | uncertain significance | Inborn genetic diseases | 2021-12-01 | criteria provided, single submitter | clinical testing | The p.R800M variant (also known as c.2399G>T), located in coding exon 8 of the SETX gene, results from a G to T substitution at nucleotide position 2399. The arginine at codon 800 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004733057 | SCV005345227 | uncertain significance | SETX-related disorder | 2024-05-03 | no assertion criteria provided | clinical testing | The SETX c.2399G>T variant is predicted to result in the amino acid substitution p.Arg800Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0036% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-135204586-C-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |